Yes‐associated protein regulates the hepatic response after bile duct ligation
Open Access
- 8 August 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 56 (3), 1097-1107
- https://doi.org/10.1002/hep.25769
Abstract
Human chronic cholestatic liver diseases are characterized by cholangiocyte proliferation, hepatocyte injury, and fibrosis. Yes-associated protein (YAP), the effector of the Hippo tumor-suppressor pathway, has been shown to play a critical role in promoting cholangiocyte and hepatocyte proliferation and survival during embryonic liver development and hepatocellular carcinogenesis. Therefore, the aim of this study was to examine whether YAP participates in the regenerative response after cholestatic injury. First, we examined human liver tissue from patients with chronic cholestasis. We found more-active nuclear YAP in the bile ductular reactions of primary sclerosing cholangitis and primary biliary cirrhosis patient liver samples. Next, we used the murine bile duct ligation (BDL) model to induce cholestatic liver injury. We found significant changes in YAP activity after BDL in wild-type mice. The function of YAP in the hepatic response after BDL was further evaluated with liver-specific Yap conditional deletion in mice. Ablating Yap in the mouse liver not only compromised bile duct proliferation, but also enhanced hepatocyte necrosis and suppressed hepatocyte proliferation after BDL. Furthermore, primary hepatocytes and cholangiocytes isolated from Yap-deficient livers showed reduced proliferation in response to epidermal growth factor in vitro. Finally, we demonstrated that YAP likely mediates its biological effects through the modulation of Survivin expression. Conclusion: Our data suggest that YAP promotes cholangiocyte and hepatocyte proliferation and prevents parenchymal damage after cholestatic injury in mice and thus may mediate the response to cholestasis-induced human liver disease. (HEPATOLOGY 2012;56:1097–1107)Keywords
This publication has 57 references indexed in Scilit:
- Mst1/2 signalling to Yap: gatekeeper for liver size and tumour developmentBritish Journal of Cancer, 2010
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in MammalsDevelopmental Cell, 2010
- Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasisDigestive and Liver Disease, 2010
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathwayNature, 2009
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- Intrahepatic Bile Ducts Develop According to a New Mode of Tubulogenesis Regulated by the Transcription Factor SOX9Gastroenterology, 2009
- Expression of Yes-associated protein in common solid tumorsHuman Pathology, 2008
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006